EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma

Stopped early · Phase 1

Conditions studied: Sarcoma

In brief

Phase I trial to study the effectiveness of EMD 121974 in treating patients who have HIV-related Kaposi's sarcoma. EMD 121974 may stop the growth of Kaposi's sarcoma by stopping blood flow to the tumor.

Key facts

Study ID

NCT00006222

Run by

National Cancer Institute (NCI)

People needed

30

Starts

2000-09-01

Expected to finish

2001-03-01

Last updated by the study team

2013-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California San Diego Cancer Center — La Jolla, California, United States
• UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
• Vanderbilt Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.